Stockreport

Gemcabene Meets Primary Endpoint in INDIGO-1 Study of Severe Hypertriglyceridemia (SHTG) Patients

GEMPHIRE THERAPEUTICS INC COMMON  (GEMP) 
Last gemphire therapeutics inc common earnings: 5/9 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.gemphire.com
PDF Gemcabene demonstrated statistically significant lowering of triglycerides (TGs) in SHTG Secondary endpoints achieved included statistically significant reductions in s [Read more]